Increasingly, the British National Health Service needs health information to be relevant and locally responsive. The public health function is particularly involved in meeting this information challenge, and has a vested interest in improving routine data quality assurance. Acting on feedback from data users illustrates responsiveness in a climate that emphasizes evidence-based action, quality assurance, health strategy with target-setting, cancer service reform, and locally-informed health care commissioning.
Quality assurance philosophy is dominated by the mainstream quartet of case ascertainment, validity, timeliness, and record completeness. 4 As used here, data cleaning refers to amendments made by the data user to the dataset after its release from the Registry (i.e. after initial in-house data manipulation). This highlights that component of validity concerning coding by Registry staff (i.e. local coding, of captured data items, using standard taxonomies) rather than accuracy measured by special re-abstraction exercises.
Breadth and depth of cleaning will differ, appropriately, with type of cancer, enquiry, and researcher. The need for a thorough yet pragmatic approach, combined with ignorance and antipathy about the nature and extent of the task, potentially deters users. Likewise, suspicions about data being too 'dirty' can deter users of the results. Indeed, explicitly tackling technical concerns about routine data may help to combat conceptual and emotional reservations. 5 Registries are unlikely to view their released datasets as devoid of internally generated coding/manipulation errors; rather, such errors are considered to be inconsequential in large population studies. For such a potentially effort-intensive yet informative activity, however, data cleaning is hardly discussed and is not studied empirically in the literature, in which the data user's perspective is generally underrepresented.
The presumed poor quality of the underused skin cancer data interested the staff of the Registry, particularly because of substantial inter-registry variation in recording practices. Furthermore, skin cancer is a useful complex prototype, because of its: (a) propensity for multiple neoplasms at multiple subsites (with ascertainment complicated by the infrequency of hospital admission); and (b) relevance to the former English Health of the Nation target. 1 Stimulated by local work towards the national health strategy, this exploratory study aimed to assess the scope for learning lessons about cancer registration quality assurance from a data user (with skin cancer as the example).
Materials and Methods

Local cancer registration practice
This population-based Registry, serving 2.4 million, is the second oldest (founded 1944) in the UK network. In its hierarchical patient-based database, each neoplasm has a separate record. For multiple neoplasms in individual patients, several unique tumour identification numbers link to a unique patient identification number. Besides registration forms, 'paper records' include: copies of source documents (some on microfiche): e.g. histopathology reports, death certificates, relevant correspondence; and a card index, for 1970-1986, indicating each occurrence of basal cell carcinoma (BCC) in an individual, which was used to supplement missing or misleading information in the main records. Paper records of BCC and squamous cell carcinomas (SCC) from 1970 to 1973 had been destroyed.
Local skin cancer registration custom and practice documented.
The study dataset and cleaning
A skin cancer dataset, extracted from the Registry database (as at 1992/1993) to produce a skin cancer bulletin, 3 included most 'minimum dataset items' (e.g. details about: patient, diagnosis, treatment, and outcome) 6,7 plus extra treatment variables ( Figure 1 ).
The data user (GM) used Statistical Package for Social Sciences for Personal Computers (SPSS-PC+) and Microsoft Excel for Windows 6 on personal computer for data cleaning and the epidemiological analysis. Although the epidemiological analysis focused on primary malignancies, data cleaning involved the whole study dataset (everything registered, except metastases) ( Figure 1 ), thereby allowing reclassification between skin cancer and the rest of the study dataset as appropriate.
Given dataset size and complexity, a pragmatic, hierarchical, and iterative approach evolved focused on the main variables ( Table 1 ). Queries were generated using 'a high index of suspicion' when viewing the preliminary frequencies and crosstabulations of the main variables, and were investigated using the paper records.
There were two main levels of enquiry reliant on uncovering errors by suspicion. (1) Investigating the frequencies and values of the main variables, e.g. morphology, for suspicious (e.g. small numbers) nonsense, or missing values ( Table 1 ).
(2) Applying more complicated logic to selected variables, e.g. inconsistencies such as treatment being recorded with a reason for no treatment being given, or duplicated 'unique' tumour identification number. Some suspected inconsistencies were confirmed but not pursued because overall impact on dataset accuracy for the main epidemiological analysis was considered to be minimal.
Before the epidemiological analysis, study dataset errors were rectified and a nested validation test was performed. A random sample was generated, using SPSS-PC+, from each of the three main clinicopathological groups (i.e. cutaneous malignant melanomas [MM], BCC and SCC). Morphology and site coding was verified. Arbitrarily assuming an error percentage below 5%, sample size calculations based on the Normal approximation for the binomial distribution were unsuitable. Exact confidence intervals involving F distribution tables were used. 9 Balancing workload and precision, a sample size of 130 for each group was For MM, availability of stage data (Breslow thickness and/or Clark's level) was assessed.
Incremental corrections were made to the study dataset to facilitate progress, accepting that this prevented cross-referral of different routes to the same error. Some suspicious dates of diagnosis (i.e. forming unlikely date sequences) were noted during epidemiological analysis and amended afterwards. The main Registry database was revised later.
Data cleaning was examined quantitatively to determine its breadth, depth, and impact. Here, site coding errors were classified as major if the true site was other than T173, minor if miscoded to another skin subsite, e.g. eyelid versus trunk. Morphology coding errors were classified here as major if the true morphology lay outside a closely related code, e.g. SCC rather than BCC, or minor if, for example, the error was between variants of BCC. The main quality assurance themes concerning coding errors were also identified qualitatively.
Results
Local skin cancer registration practice
Registry practice was to register only the first BCC per individual, and all other type of 'multiples' ascertained in an individual, i.e. whether MM, SCC, and/or other types of skin cancer. Occurrence but not the number of subsequent BCC had been recorded, historically, by changing the 4th digit of the ICD-O site code to T173.8 ('between sites'). This lost the subsite location of the first BCC, and made the fact of multiple BCC indistinguishable from a single BCC occurring 'between sites'.
The study dataset and cleaning
This 1970-1992 study dataset ultimately contained over 30 000 'tumour records', of 217 character-length (59 variables). The main epidemiological analysis was on 30 045 known primary skin cancers in 28 952 local residents ( Figure 2 ).
Registry paper records were sought during data checking on approximately 1685 occasions (excluding the nested validation, n = 1269 [ Table 1 ]). Only 2.9% (49) of these records were unavailable, and most queries arose from morphology and/or operation coding (Table 1 ). Some checks (e.g. 'date of birth pre-1870 or post-1990') did not yield any queries. Some 'lowimpact' inconsistencies were identified, but not pursued or rectified ( Figure 2 ).
Only 0.3% of cases in the study dataset (97/33 132) were found to be ineligible for inclusion, mostly (52/97, 53.6%) due to major miscoding of site alone, and mostly (57/97, 58.8%) uncovered during morphology checks ( Figure 2 ). Before random coding checks (see below), morphology errors were detected in 0.5% (152/33 132) of cases, 116 (76.3%) of these being major, i.e. miscoded beyond closely related codes.
After cleaning, morphology coding errors in the three main diagnostic groups were minimal in random samples ( Table 2) . Only SCC showed major morphology coding errors, affecting 2.4% (95% CI : 0.5-6.7%). All BCC with a site code of T173.8 were true multiple BCC rather than single BCC 'between sites'. In 5.4% of people with BCC, however, further BCC were recorded in the paper records but not on the computer system.
Of MM, 32.3% (41/127) had stage data (i.e. Breslow thickness and/or Clark's level) noted in the registry-held paper records, all registered from 1981 onwards, for which time period 49.4% (41/83) had this information. Of the minor morphology errors for MM, in 62.1% (18/29) 'superficial spreading' subtype was not coded.
After the main epidemiological analysis, 21 records were available to check 27 cases suspected of having year of registration predating recorded year of diagnosis. Unlike a further 293 uncovered consequently (Figure 2 ), these 21 were unexplained, SKIN CANCER REGISTRATION QUALITY ASSURANCE 811 
Main qualitative observations on data quality
Imputing date of diagnosis from a hierarchy (i.e. date of: first treatment in hospital, or first seen at hospital, or general practitioner referral to hospital, or presentation to the general practitioner) was vulnerable to unintentional alteration.
Range, cross-referencing, and safety checks were insufficient at data entry on the computer system, e.g. allowing inappropriate date sequences; blank and nonsense values, overwriting of records, and duplication (10/33 132, 0.03%) of 'unique' tumour identification numbers (mostly with multiple BCC).
Basal cell carcinoma registration practice was especially problematic.
Misconceptions contributed to miscoding. (a) Morphology misclassification, e.g. overlooking 'superficial spreading' subtype of MM in histopathology reports. (b) Site misclassification, e.g. nipple lesions to skin of trunk (which excludes nipple). (c) Treatment misclassification, e.g. cryotherapy to a chemotherapy code (confusing nitrogen mustard with liquid nitrogen). The aberrant code was entered three times under the surgical operations variable; when an improbable 83 were then found 
Discussion
There is great scope for data users to contribute to cancer registration quality assurance. While standard cancer registration texts cover routine quality assurance issues, highlighting the benefits of critical use, 10, 11 this exploratory study is unique in quantifying the cleaning of a skin cancer registration dataset from the user's perspective. The need to recognize the fallibility of all human processes rather than pursue the mirage of data perfection is evident, as are transferable messages for other cancer sites, registries, and researchers. Indeed, the broader implications for other site-specific cancers remain even if skin cancer does sit at the worst end of a spectrum of cancer data coding quality.
A caveat is that this data user had the advantage of specialist knowledge in both histopathology and public health medicine, and working closely with the Registry on an essentially 'inhouse' project. This also means, however, that the level of difficulties encountered with the dataset might be much greater for many other users.
The hierarchical and iterative data cleaning method contained elements of art and science, balanced pragmatism with a systematic approach, and used index of suspicion incrementally to correct coding errors. It would have been unrealistic to expect to quantify, comprehensively, the overall quality of coding, however, for various reasons. These included, for example: the subjectivity involved; time constraints versus potential impact; ever-changing denominators for calculating the proportional impact of many manoeuvres; and inability to retrieve into the dataset lesions coded wrongly as secondaries or to non-skin sites (Figure 3 ).
Nevertheless, the study dataset appeared fit for the designated purpose. Reclassification out of the dataset (0.3%) had a negligible impact on subsequent epidemiological analyses. The major misclassifications were mostly detected by morphology checks. Cleaning strategies should focus on such checks, both directly and indirectly (e.g. via treatment). The credibility of the 0.3% estimate was also supported by the nested validation failing to uncover any ineligible cases. It is reasonable to assume that misclassification beyond the study dataset (to secondary or to non-skin sites) was similar in magnitude, and overall quality appeared good.
Paradoxically, however, quantitatively, and only with hindsight, the cleaning exercise proved unnecessary for the designated epidemiological purpose but, qualitatively, without it, several important quality assurance issues raised might otherwise have remained hidden. (a) Local custom and practice: no written guidance for researchers' datasets; recording the fact of further BCC by writing over the subsite code of the first BCC. Cancer registration data cleaning requires medical, registration, and information technology expertise, and stamina. Despite difficulties anticipating task size, the cleaning strategy should be customized to minimize effort. Queries need prioritizing (feasibility versus importance) ( Figure 4) . A mechanism for influencing systematic ongoing quality assurance, including computer system development, is also necessary.
Ideally, most cancer registry data should only be released for independent use when there is a sufficient in-house understanding of the main quality assurance problems. Realistically, a practical balance is needed between the levels of prevention of coding errors: (a) avoiding their introduction (primary prevention); (b) early detection by in-house quality assurance and special projects (secondary prevention); (c) releasing data SKIN CANCER REGISTRATION QUALITY ASSURANCE 813 for independent use after applying a preliminary minimum data cleaning protocol with site-specific modifications, and supporting external users to recognize, interpret, and report back about errors (tertiary prevention). Known problem areas (e.g. idiosyncratic registration practices; 'immortals', i.e. elderly patients recorded improbably as 'alive') need highlighting, so that their impact can be appreciated and/or addressed. The registration process for multiple BCC is problematic, because BCC is relatively common and of low perceived impact compared with other cancer types. Locally, however, idiosyncratic Registry practice generated further errors in re-accessed records. The proportion of MM paper records containing stage data was low, and this needs improving if staging is to become a meaningful core data item.
Conclusion
In the reflective cancer registration data cleaning undertaken here, uncertainties remain about: (a) striking a cost-effective balance between the levels of prevention of coding errors; (b) defining data cleaning limits, and balancing qualitative and quantitative approaches (seemingly trivial errors will interest the Registry if there are major transferable messages for other cancer sites or training, etc.; data users might be more interested in problem size); (c) defining: fitness for purpose and/or quality assurance ideals; the support requirements of external users; and the extent to which users will fulfil their responsibilities to provide quality assurance feedback (in their reciprocal relationship with the Registry); (d) the optimal way of registering multiple BCC.
The last of these prompted a nationwide baseline survey of cancer registries that confirmed the variability of skin cancer registration, particularly of BCC. 12 Despite sophisticated computer systems and worthy intentions, errors are inherent in routinely collected data, 13 of which cancer registration data provide but one example, and feedback from data users is invaluable. Indeed, there is a long history of publication on the quality of cause-of-death data, 14 Suggested priority-setting mechanism for coding queries to pursue when cleaning a cancer registration dataset (schematic). Feasibility versus importance
